USPTO grants patent to ULURU's Altrazeal product - 研发专利新闻

添加时间:2011-04-07 原文发表:2011-03-24 人气:2

ULURU Inc. (NYSE AMEX: ULU) announced today that it has been issued U.S. Patent 7,910,135 Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses. This patent provides additional coverage for Altrazeal and...

查看所有的文章内容需要 VIP会员权限查看

点这里复制本页地址发送给您QQ/MSN上的好友

• NephRx receives new U.S. patent for NX00

• PRWP receives two new patents for Galect

• POZEN files motion for Treximet patent l

• BDSI's BEMA drug delivery technology rec

• USPTO grants patent to HistoRx methods f

• GenSpera strengthens intellectual proper

• USPTO rejects Biotage's re-examination a

• HPK receives Reissue Patent for digital

• Global settlement agreement reached in T

• Argentum responds to recent decision in

• NephRx receives new U.S. patent for NX00

• ACT to be awarded broad patent protectio

• Colorcon announces specific details on i

• VARI, Gentel Biosciences receive U.S. Pa

• USPTO issues Notice of Allowance to Alph

• US District Court rules against Watson i

• U.S. District Court rules in favor of Wa

• Biotectix acquires Chameleon BioSurfaces

• USPTO issues Notice of Allowance to Modu

• USPTO issues patent to Somaxon's Silenor

网站首页

行业信息

市场快讯

SFDA新闻精选

调研报告

研发动态

研发专利新闻

新闻公告

您的位置：网站名称 → 研发专利新闻 → 正文